Annual balance sheet for Avai Bio, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 0.033 | 0.107 | 0 | 0.081 | 0.023 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.171 | 0 | — | — | 0.06 |
| Prepaid Expenses | |||||
| Total Current Assets | 0.331 | 0.108 | 0.116 | 0.093 | 0.089 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0 | 0 | 0 | — | — |
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 0.455 | 0.241 | 0.322 | 0.225 | 0.573 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.86 | 0.875 | 1.79 | 1.79 | 3.39 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 0.86 | 0.875 | 1.79 | 1.79 | 3.39 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | -0.406 | -0.633 | -1.47 | -1.56 | -2.82 |
| Total Liabilities & Shareholders' Equity | 0.455 | 0.241 | 0.322 | 0.225 | 0.573 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |